Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice

This publication has 21 references indexed in Scilit:

• The humoral immune response to the kinetoplastid membrane protein-11 in patients with American Leishmaniasis and Chagas disease: prevalence of IgG subclasses and mapping of epitopes
  Immunology Letters, 2000
• Genetic Immunization with Glycoprotein 63 cDNA Results in a Helper T Cell Type 1 Immune Response and Protection in a Murine Model of Leishmaniasis
  Human Gene Therapy, 1998
• Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major
  The Journal of Experimental Medicine, 1997
• Leishmania vaccines: Old and New
  Parasitology Today, 1997
• Leishmaniasis: Immunological and clinical aspects and vaccines in venezuela
  Clinics in Dermatology, 1996
• Vaccines against leishmaniasis
  Pathogens and Global Health, 1995
• Expression Cloning of a Protective Leishmania Antigen
  Science, 1995
• The Regulation of Immunity to Leishmania Major
  Annual Review of Immunology, 1995
• Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection
  Infection and Immunity, 1993
• Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
  The Journal of Experimental Medicine, 1993